Stockreport

Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Intrinsic Value Is Potentially 99% Above Its Share Price [Yahoo! Finance]

Cytek Biosciences, Inc.  (CTKB) 
PDF Cytek Biosciences is estimated to be 50% undervalued based on current share price of US$5.34 The US$8.70 analyst price target for CTKB is 18% less than our estimate o [Read more]